Enrique Angeles

Dr. Enrique Angeles

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2009 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
JIJosé Manuel Islas-Martínez
José Manuel Islas-Martínez
DRDamaris Rodríguez-Barrientos
Damaris Rodríguez-Barrientos
Annia GalanoAnnia Galano
Annia Galano
EAEnrique Angeles
Enrique Angeles
LTLuis A. Torres
Luis A. Torres
ARAlberto Rojas-Hernández
Alberto Rojas-Hernández

1 October 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
VAVictor H. Abrego
Victor H. Abrego
BMBeatriz Martínez-Pérez
Beatriz Martínez-Pérez
LTLuis A. Torres
Luis A. Torres
EAEnrique Angeles
Enrique Angeles
LMLuisa Martínez
Luisa Martínez
ARAlberto Rojas-Hernández
Alberto Rojas-Hernández

19 January 2023 in ChemistrySelect
Verified
Journal Article
Open access
VVVíctor Hugo Vázquez‐Valadez
Víctor Hugo Vázquez‐Valadez
MOMaría Virginia Oliva‐Arellano
María Virginia Oliva‐Arellano
PMPablo Arturo Martínez‐Soriano
Pablo Arturo Martínez‐Soriano
MHManuel Alejandro Hernández‐Serda
Manuel Alejandro Hernández‐Serda
AVAna María Velázquez‐Sánchez
Ana María Velázquez‐Sánchez
EAEnrique Angeles
Enrique Angeles
In this paper, the quantitative structure‐activity relationship predictive models (QSAR) are presented: the prediction model for some of the main components of cannabis sativa, acute toxicity LD50 (n=45, r2=0.917, q2=0.902), chronic toxicity LOAEL (n=35, r2=0.911, q2=0.868), NOAEL(n=22, r2=0.964, q2=0.937), LOEL (n=26, r2=0.911, q2=0.863) and NOEL (n=25, r2=0.867, q2=0.802), in addition to carcinogenicity and mutagenicity effects. Only for the case of LD50, the values reported in the literature of the delta 9‐THC compound present in Cannabis sativa were taken into account and this model was applied to the other compounds present in the plant, which we consider the most relevant since they fell from the allowed domain for QSAR Toolbox to predict the LD50 of each of them, while the other additional endpoints were established according to the methodology that marks the QSAR Toolbox software. The application of these models and predictions allowed us to predict the permissible daily exposure (PDE) and acceptable daily intake (ADI) values of some of the cannabis components. This work aims to present important elements of the toxicology of some of the components of the plant that serve only as a reference and does not intend to favor or inhibit the use of cannabis for medicinal or recreational use.

30 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Liseth Rubí Aldaba-MuruatoLiseth Rubí Aldaba-Muruato
Liseth Rubí Aldaba-Muruato
BEBrayan Escalante-Hipólito
Brayan Escalante-Hipólito
AAAldo Yoshio Alarcón-López
Aldo Yoshio Alarcón-López
PSPablo Arturo Martínez Soriano
Pablo Arturo Martínez Soriano
EAEnrique Angeles
Enrique Angeles
JMJosé Roberto Macías-Pérez
José Roberto Macías-Pérez
Background: Liver diseases are a global health issue with an annual mortality of 80,000 patients, mainly due to complications that arise during disease progression, as effective treatments are lacking. Objectives: This study evaluated the hepatoprotective effects of two derivatives of cinnamic acid, LQM717 and LQM755, in a murine model of acute liver damage induced by carbon tetrachloride (CCl4, 4 g/kg, single dose p.o.). Methods: Male Wistar rats were pretreated with five doses of LQM717 (20 mg/kg i.p.) or LQM755 (equimolar dose), starting 2 days before inducing hepatotoxic damage with CCl4. Results: The key parameters of hepatocellular function and damage showed significant increases in ALT, ALP, GGT, and total and direct bilirubin in rats intoxicated with CCl4, with decreased liver glycogen and serum albumin. Macroscopic and microscopic liver examinations revealed reduced inflammation, necrosis, and steatosis in animals pretreated with LQM717 or LQM755. Hepatomegaly was observed only in the LQM717 + CCl4 group. LQM755 statistically provided partial protection against increases in ALT and ALP and completely prevented elevations in GGT and total and direct bilirubin. LQM755 completely prevented albumin reduction, while LQM717 only partially prevented it. Both compounds partially prevented glycogen depletion. Bioinformatic analysis identified 32 potential liver protein targets for LQM717 and 36 for LQM755. Conclusions: These findings suggest that LQM717 and LQM755 have significant hepatoprotective effects against CCl4-induced acute liver injury, providing information for future studies in other acute and chronic models, as well as to elucidate their mechanisms of action.

1 January 2024 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
AAAldo Yoshio Alarcón-López
Aldo Yoshio Alarcón-López
MSManuel Alejandro Hernández Serda
Manuel Alejandro Hernández Serda
PAPablo Aguirre-Vidal
Pablo Aguirre-Vidal
LGLUIS ALFONSO CARDENAS GRANADOS
LUIS ALFONSO CARDENAS GRANADOS
VVVíctor Vázquez-Valadez
Víctor Vázquez-Valadez
EAEnrique Angeles
Enrique Angeles
In this research, a meticulous screening process was conducted using four servers: Drug Target Explorer, Swiss Target Predictor, SEA Predictor, and Target Hunter. The primary objective was to identify a series of potential biological targets related to the regulation of cell growth and apoptosis in cancer cells using cinnamic acid derivatives. This study focused on five specific targets, matrix metallopeptidase 9 (MMP9), apoptosis inducing factor (AIF), aldo-keto reductase family 1 member C3 (AKR1C3), aldo-keto reductase family 1 member B10 (AKR1B10), mitogenactivated protein kinase 14 (MAPK14), all of which are well known to play a significant role in cancer cell dynamics. To explore both molecular recognition and molecular dynamics, a series of in silico investigations (docking and molecular dynamics) were carried out using a collection of 14 cinnamic acid derivatives, including cinnamic acid phenethyl ester (CAPE) as a notable reference molecule due to its widely recognized anticancer effects. Furthermore, preliminary in vitro data revealed a potentially promising cytotoxic effect of (E)-N-[(3,4-dichlorophenyl)methyl]- 3-(4-phenoxyphenyl)-2-propenamide (LQM755) on a human gastric adenocarcinoma cell-line (AGS cells), which are characterized by the overexpression of the MMP9 protein. Therefore, the chemical compound LQM755 provides an initial perspective in the field of cancer therapy.

Verified
Journal Article
Open access
PDF file
Liseth Rubí Aldaba-MuruatoLiseth Rubí Aldaba-Muruato
Liseth Rubí Aldaba-Muruato
SBSandra Sánchez Barbosa
Sandra Sánchez Barbosa
VRVíctor Hugo Rodríguez-Purata
Víctor Hugo Rodríguez-Purata
GCGeorgina Cabrera-Cruz
Georgina Cabrera-Cruz
EREstefany Rosales-Domínguez
Estefany Rosales-Domínguez
JMJosé Roberto Macías-Pérez
José Roberto Macías-Pérez
Tert-butylhydroquinone (TBHQ) is a synthetic food antioxidant with biological activities, but little is known about its pharmacological benefits in liver disease. Therefore, this work aimed to evaluate TBHQ during acute liver damage induced by CCl4 (24 h) or BDL (48 h) in Wistar rats. It was found that pretreatment with TBHQ prevents 50% of mortality induced by a lethal dose of CCl4 (4 g/kg, i.p.), and 80% of BDL+TBHQ rats survived, while only 50% of the BDL group survived. Serum markers of liver damage and macroscopic and microscopic (H&E staining) observations suggest that TBHQ protects from both hepatocellular necrosis caused by the sublethal dose of CCl4 (1.6 g/kg, i.p.), as well as necrosis/ductal proliferation caused by BDL. Additionally, online databases identified 49 potential protein targets for TBHQ. Finally, a biological target candidate (Keap1) was evaluated in a proof-of-concept in silico molecular docking assay, resulting in an interaction energy of −5.5491 kcal/mol, which was higher than RA839 and lower than monoethyl fumarate (compounds known to bind to Keap1). These findings suggest that TBHQ increases the survival of animals subjected to CCl4 intoxication or BDL, presumably by reducing hepatocellular damage, probably due to the interaction of TBHQ with Keap1.